BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12430182)

  • 21. Combined effect of genetic polymorphisms in P53, P73, and MDM2 on non-small cell lung cancer survival.
    Liu L; Wu C; Wang Y; Zhong R; Duan S; Wei S; Lin S; Zhang X; Tan W; Yu D; Nie S; Miao X; Lin D
    J Thorac Oncol; 2011 Nov; 6(11):1793-800. PubMed ID: 21841506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of functional polymorphisms of P53 and P73 genes with the risk of prostate cancer in a case-control study from Northern India.
    Mittal RD; George GP; Mishra J; Mittal T; Kapoor R
    Arch Med Res; 2011 Feb; 42(2):122-7. PubMed ID: 21565625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The p73 polymorphisms are not associated with susceptibility to esophageal squamous cell carcinoma in a high incidence region of China.
    Ge H; Wang YM; Cao YY; Chen ZF; Wen DG; Guo W; Wang N; Zhang XF; Li Y; Zhang JH
    Dis Esophagus; 2007; 20(4):290-6. PubMed ID: 17617876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No association between p73 G4C14-to-A4T14 polymorphism and the risk of lung cancer in a Korean population.
    Choi JE; Kang HG; Chae MH; Kim EJ; Lee WK; Cha SI; Kim CH; Jung TH; Park JY
    Biochem Genet; 2006 Dec; 44(11-12):543-50. PubMed ID: 17136456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations between P53 Arg72Pro and development of digestive tract cancers: a meta-analysis.
    Liu L; Wang K; Zhu ZM; Shao JH
    Arch Med Res; 2011 Jan; 42(1):60-9. PubMed ID: 21376265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined analysis of the association between p73 G4C14-to-A4T14 polymorphisms and cancer risk.
    Wang L; Gao R; Yu L
    Mol Biol Rep; 2012 Feb; 39(2):1731-8. PubMed ID: 21617940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between the p73 G4C14-to-A4T14 polymorphism and risk of nasopharyngeal carcinoma: a case-control and family-based study.
    Zhang X; Cao P; Zhai Y; Zhang H; Cui Y; Wu Z; Yuan X; Wang Z; Li P; Yu L; Xia X; He F; Zhou G
    Carcinogenesis; 2014 Sep; 35(9):1977-82. PubMed ID: 24590897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p73 G4C14-to-A4T14 polymorphism and risk of lung cancer.
    Li G; Wang LE; Chamberlain RM; Amos CI; Spitz MR; Wei Q
    Cancer Res; 2004 Oct; 64(19):6863-6. PubMed ID: 15466174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of p73 G4C14-to-A4T14 polymorphism at exon 2 with the response of human lung adenocarcinoma cell lines to chemotherapy.
    Liu K; Jiang L; Zhou X
    Cell Biol Int; 2010 Jan; 34(2):185-8. PubMed ID: 19947923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of p73 G4C14-A4T14 polymorphisms with genetic susceptibilities to breast cancer: a case-control study.
    Zhou X; Wu C
    Med Oncol; 2012 Dec; 29(5):3216-21. PubMed ID: 22535334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphisms at p53, p73, and MDM2 loci modulate the risk of tobacco associated leukoplakia and oral cancer.
    Misra C; Majumder M; Bajaj S; Ghosh S; Roy B; Roychoudhury S
    Mol Carcinog; 2009 Sep; 48(9):790-800. PubMed ID: 19204927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dinucleotide polymorphism of p73 gene is associated with a reduced risk of lung cancer in a Chinese population.
    Hu Z; Miao X; Ma H; Tan W; Wang X; Lu D; Wei Q; Lin D; Shen H
    Int J Cancer; 2005 Apr; 114(3):455-60. PubMed ID: 15578704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p73 G4C14 to A4T14 polymorphism is associated with colorectal cancer risk and survival.
    Lee KE; Hong YS; Kim BG; Kim NY; Lee KM; Kwak JY; Roh MS
    World J Gastroenterol; 2010 Sep; 16(35):4448-54. PubMed ID: 20845513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers.
    Chen X; Sturgis EM; El-Naggar AK; Wei Q; Li G
    Carcinogenesis; 2008 Nov; 29(11):2120-5. PubMed ID: 18701437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of combined p73 and p53 genetic variants with tumor HPV16-positive oropharyngeal cancer.
    Wang Z; Sturgis EM; Guo W; Song X; Zhang F; Xu L; Wei Q; Li G
    PLoS One; 2012; 7(4):e35522. PubMed ID: 22523600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic association between p73 G4C14-A4T14 polymorphism and risk of squamous cell carcinoma.
    Xia S; Fang L; He J; Zhao Z; Xie F; Li H
    Clin Exp Med; 2016 Feb; 16(1):49-55. PubMed ID: 25516466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p73 G4C14-to-A4T14 polymorphism and risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never smokers and never drinkers.
    Chen X; Sturgis EM; Etzel CJ; Wei Q; Li G
    Cancer; 2008 Dec; 113(12):3307-14. PubMed ID: 18988287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different risk relations with smoking for non-small-cell lung cancer: comparison of TP53 and TP73 genotypes.
    Hiraki A; Matsuo K; Hamajima N; Ito H; Hatooka S; Suyama M; Mitsudomi T; Tajima K
    Asian Pac J Cancer Prev; 2003; 4(2):107-12. PubMed ID: 12875622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphisms of TP53 Arg72Pro, but not p73 G4C14>A4TA4 and p21 Ser31Arg, contribute to risk of cutaneous melanoma.
    Li C; Chen K; Liu Z; Wang LE; Gershenwald JE; Lee JE; Prieto VG; Duvic M; Grimm EA; Wei Q
    J Invest Dermatol; 2008 Jun; 128(6):1585-8. PubMed ID: 18049450
    [No Abstract]   [Full Text] [Related]  

  • 40. [p73 polymorphisms and clinicopathologic characteristics in breast cancer].
    Zhou X; Wu C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 37(3):238-43. PubMed ID: 22561492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.